It has been reported that CHIP could bind to NF-κB subunit RelA and trigger its ubiquitination and proteasomal mediated degradation, which further terminate the canonical NF-κB activity and suppress IL-8-induced angiogenesis in GC cells [6]. The gene discussed is NFKB1; the disease is gastric cancer.